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Naþ/glucose co-transporter 1 (SGLT1) transports dietary sugars from the lumen of the intestine into enterocytes. Regulation of this protein is
essential for the provision of glucose to the body and, thus, is important for maintenance of glucose homeostasis. We have assessed expression
of SGLT1 at mRNA, protein and functional levels in the intestinal tissue of 28 d old piglets weaned onto isoenergetic diets with differing
concentrations of digestible carbohydrate (CHO). We show that expression of SGLT1 remains constant when piglets are fed up to 40 % CHO-
containing diets. However, there is a significant increase in SGLT1 expression when the CHO content of the diet is . 50 %. Morphometric
analyses indicate that the increased expression is not due to a trophic effect. It has been proposed that in rat intestine, in response to a high-
CHO diet, GLUT2 (the classical basolateral membrane monosaccharide transporter) is translocated to the luminal membrane of enterocytes to
absorb excess dietary glucose. We show, using immunohistochemistry and Western blotting with antibodies raised to amino acids in different
epitopes of GLUT2, that under all dietary conditions, low to high CHO, GLUT2 is expressed on the basolateral membrane of pig enterocytes.
Furthermore, functional studies indicate that there is no uptake of 2-deoxy-D-glucopyranoside, a specific substrate of Naþ-independent glucose
transporters into brush-border membrane vesicles isolated from the intestines of piglets either maintained on low- or high-CHO diets.
Thus, SGLT1 is the major route for absorption of dietary sugars across the luminal membrane of swine enterocytes.
Na1/glucose co-transporter 1: GLUT2: Dietary carbohydrates: Weaned piglets
The classical model of intestinal sugar transport is that glucose
and galactose are transported from the lumen of the intestine
into enterocytes by the Naþ/glucose co-transporter 1
(SGLT1), whereas fructose is transported by a facilitated,
Na-independent transporter, GLUT5. Glucose, galactose and
fructose, once accumulated in the cells, are released from
the cytosol across the basolateral membrane into the systemic
system by another facilitated Naþ-independent monosacchar-
ide transporter, GLUT2(1,2).
It has been suggested, however, that in the intestine of
rodents, in response to a high-carbohydrate (CHO) diet,
or intestinal infusion with high concentrations of glucose or
fructose, GLUT2 is translocated to the luminal membrane
of enterocytes to absorb dietary glucose or fructose(3,4), imply-
ing that GLUT2, as well as SGLT1, is involved in the
uptake of dietary sugars. In support of this proposition
Gouyon et al.(5) have reported that in GLUT2-knockout
mice, fructose uptake in the intestinal brush-border membrane
vesicles (BBMV) was half of that in the wild-type mice,
indicating that brush-border membrane GLUT2 absorbs 50 %
of luminal fructose(5).
In contrast, it has been demonstrated by Barone et al.(6) that
GLUT5-knockout mice cannot absorb fructose. Furthermore,
these workers have shown that the absorption of glucose
across the brush-border membrane of GLUT5-knockouts is
solely accomplished by SGLT1, concluding the lack of invol-
vement of luminal GLUT2 in monosaccharide absorption(6).
Moreover, in glucose–galactose malabsorption, which results
from mutations within the SGLT1 gene(7,8), human infants
cannot absorb glucose or galactose. Fructose, however, can
be absorbed normally(7), indicating the presence of a func-
tional transcellular route via luminal GLUT5 and basolateral
GLUT2 for the absorption of fructose. The presence of
GLUT2 on the luminal membrane would forestall the chronic
and potentially fatal diarrhoea experienced by these children,
suggesting that the expression of GLUT2 on the luminal
membrane does not extend to humans.
In the light of these controversies it was essential to identify
the candidate glucose transporter and the properties of glucose
uptake across the brush-border membrane of piglets’ entero-
cytes. Moreover, this information was needed as the baseline
for the proceeding paper(9) addressing the effect of artificial
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sweeteners, routinely included in weaning piglets’ diet, on the
capacity of the gut to absorb dietary sugars.
It has been shown, using high and low concentrations, 1·9 v.
70·0 % CHO-containing diets, that expression of SGLT1 and
the capacity of the gut to absorb glucose in rodents is
enhanced in response to a high-CHO diet(10 – 12). However,
very little information is available on the threshold concen-
tration required to stimulate SGLT1 up-regulation. It was
important therefore, to assess the intestinal capacity of piglets
to absorb glucose in response to increasing concentrations of
dietary CHO.
In the present paper we have assessed the expression of
SGLT1 and GLUT2 in the intestinal tissues of weaned piglets
maintained on isoenergetic diets with differing concentrations
of digestible CHO. Collectively, the data demonstrate that,
in pig intestine, SGLT1 is the major route for absorption of
dietary glucose from the lumen of the intestine into entero-
cytes. Furthermore, the intestinal capacity (via SGLT1) to
absorb glucose becomes limiting when the CHO content
of the diet is . 50 %; to avoid malabsorption, there is an
up-regulation in SGLT1 expression.
Methods
Animals, diets and tissue collection
Male and female suckling Landrace £ Large White piglets
(28 d old) were placed in pairs into standard pens measuring
1·5 m £ 1·5 m in a room with continuous heating (26·78C)
and a 12 h light–dark cycle. To avoid any dietary contribution
from the bedding, dust-extracted wood shavings were used.
All animals had free access to food and water. The left-over
food and water not consumed per d by each pair were
recorded. Diets were obtained from Purina Mills (Richmond,
IN, USA). The piglets were weaned onto isoenergetic
(15·82 kJ/g) diets differing in the amount of CHO, with nutri-
tional profiles depicted in Table 1. The CHO content of the
diets consisted mainly of maize starch with a small amount
of sucrose. The diets contained the following CHO contents:
7·0 % (test diet no. 5S5R); 35·9 % (test diet no. 5S5Q);
52·6 % (test diet no. 5SK7); 60·3 % (test diet no. 5S5S).
Each group, consisting of between eight and twelve piglets,
was fed for 3 d either the 7·0, 35·9, 52·6 or 60·3 % CHO-
containing diet. The animals remained healthy throughout
the experiment, and had no sign of enteric disturbances. Sub-
sequently, they were killed with an intravenous injection of
20 ml pentobarbitone (200 mg/ml, Pentoject; AnimalCare
Ltd, York, UK) to the cranial vena cava (in line with the
UK Home Office schedule 1 regulation). Immediately, sec-
tions of the small intestine approximately 40 cm in length
were removed from the proximal (distal to the gastric
pylorus), mid- (half way along the small intestine) and distal
(proximal to the ileo-caecal junction) small intestine. The
gut samples were everted, rinsed with ice-cold saline, wrapped
in aluminium foil and frozen immediately in liquid N2.
Following transportation to the laboratory, frozen tissue
samples were stored at 2808C until use. Small sections
(1–2 cm) of fresh tissue from each region were fixed for histo-
logical and immunohistochemical examinations. Histological
examination of samples of fixed tissues confirmed that they
were intact, with epithelial cells attached.
Isolation of brush-border membrane vesicles
BBMV were prepared as described by Shirazi-Beechey
et al.(13). All steps were carried out at 48C. Briefly, sections
of everted small intestine were thawed in a buffer (100 mM-
mannitol, 2 mM-HEPES/2-amino-2-hydroxymethyl-propane-
1,3-diol (Tris); pH 7·1), cut into 1–2 cm pieces and vibrated
for 1 min at maximum speed using a Vibromixer (Alpha
Laval, Eastbourne, East Sussex, UK). In this procedure
epithelial cells are shed into the medium. Subsequently, the
suspension was filtered through a Bu¨chner funnel to remove
muscle and connective tissues. The filtrate was then homogen-
ised using a Polytron (Ystral, Cambridge, UK) for 2 £ 30 s.
The resulting homogenate was then filtered through two
layers of nylon gauze. Next, MgCl2 was added to a final
concentration of 10 mM and the solution was stirred on ice
for 20 min. The homogenate was then centrifuged for 10 min
at 3000 g (SS34 rotor; Sorvall, Stevenage, Herts, UK) and
the resulting supernatant fraction was further centrifuged for
30 min at 30 000 g. The pellet was suspended in a buffer
(100 mM-mannitol, 0·1 mM-MgSO4 and 20 mM-HEPES/Tris;
pH 7·1) and homogenised with ten strokes of a Potter-Elvehjem
Teflon hand-held homogeniser (Fischer Scientific UK Ltd,
Loughborough, Leics, UK) before centrifuging for 30 min
at 30 000 g. The final pellet was re-suspended in an isotonic
buffer (300 mM-mannitol, 0·1 mM-MgSO4 and 20 mM-HEPES/
Tris; pH 7·4) and homogenised by passing through a twenty-
seven-gauge needle several times. The BBMV were divided
into samples and stored in liquid N2 until use. The protein
concentration in the original cellular homogenate and
Table 1. Nutritional profile of the diets (%)
Test diet. . . 5S5R 5S5Q 5SK7 5S5S
Protein 47·30 25·00 22·20 18·10
Arginine 4·49 2·35 2·06 1·66
Histidine 1·41 0·74 0·65 0·52
Isoleucine 3·22 1·68 1·48 1·19
Leucine 5·23 2·73 2·40 1·93
Lysine 4·29 2·24 1·97 1·58
Methionine 1·27 0·86 0·80 0·72
Cystine 1·81 0·95 0·83 0·67
Phenylalanine 3·42 1·79 1·57 1·26
Tyrosine 2·28 1·19 1·05 0·84
Threonine 2·95 1·54 1·35 1·09
Tryptophan 0·87 0·46 0·40 0·32
Valine 3·29 1·72 1·51 1·21
Alanine 2·14 1·12 0·98 0·79
Aspartic acid 5·90 3·08 2·71 2·18
Glutamic acid 9·19 4·80 4·21 3·39
Glycine 2·21 1·16 1·01 0·82
Proline 2·51 1·31 1·15 0·93
Serine 2·62 1·37 1·20 0·97
Fat 18·20 15·20 9·20 7·50
Linoleic acid 10·35 8·64 5·20 4·21
Linolenic acid 0·17 0·14 0·09 0·07
n-3 Fatty acids 0·16 0·14 0·08 0·07
Total SFA 2·30 1·92 1·16 0·94
Total MUFA 4·37 3·65 2·20 1·78
PUFA 10·39 8·71 5·23 4·23
Fibre 5·60 10·40 3·80 3·50
Carbohydrate 7·00 35·90 52·60 60·30
Maize starch 5·48 24·88 43·65 51·36
Sucrose 0·50 10·00 8·00 8·00
A. W. Moran et al.648
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BBMV was estimated by its ability to bind Coomassie blue
according to the Bio-Rad assay technique (Bio-Rad, Hemel
Hempstead, Herts, UK). Porcine g-globulin was used as the
standard.
Disaccharide enzyme assays
Maltase and sucrase activities were measured at 388C in
BBMV isolated from the intestine of piglets on diets of vary-
ing CHO content as described previously(13 – 15) using maltose
or sucrose as substrates respectively. D-Glucose released,
as the result of substrate hydrolysis, was measured using a
commercial kit (R-Biopharm Rhoˆne Ltd, Glasgow, UK).
Measurement of monosaccharide transport
Naþ-dependent glucose uptake into BBMV was measured as
described(12,13,15). The uptake of D-glucose was initiated by
the addition of 100ml of incubation medium containing
100 mM-NaSCN (or KSCN), 100 mM-mannitol, 20 mM-
HEPES/Tris (pH 7·4), 0·1 mM-MgSO4, 0·02 % (w/v) NaN3 and
0·1 mM-[U-14C]-D-glucose (GE Healthcare, Little Chalfont,
Bucks, UK) to BBMV (100mg protein). The reaction was
stopped after 3 s by the addition of 1 ml of ice-cold stop
buffer containing 150 mM-KCl, 20 mM-HEPES/Tris (pH 7·4),
0·1 mM-MgSO4, 0·02 % (w/v) NaN3 and 0·1 mM-phlorizin.
A 0·9 ml portion of the reaction mixture was removed and
filtered under vacuum through a 0·22mm pore cellulose acet-
ate–nitrate filter (GSTF02500; Millipore, Watford, Herts,
UK). The filter was washed with 5 £ 1 ml of ice-cold stop
buffer, placed in a vial containing 4 ml of scintillation fluid
(Scintisafe; Fisher Scientific, Loughborough, Leics, UK) and
the radioactivity retained on the filter measured using a LS
6500 multi-purpose scintillation counter (Beckman-Coulter,
High Wycombe, Bucks, UK). All uptakes were measured
in triplicate. To assess the activity of any potential facilitated
glucose transporter, the initial rate of uptake of 1 mM-2-deoxy-
D-glucopyranoside, a specific substrate of Naþ-independent
D-glucose transport isoforms, into BBMV was determined at
388C. The incubation medium consisted of 300 mM-mannitol,
20 mM-HEPES/Tris (pH 7·4), 0·1 mM-MgSO4, 0·02 % (w/v)
NaN3 and 1 mM-[U-
14C]-2-deoxy-D-glucose.
Western blot analysis
The abundance of SGLT1 protein in cellular homogenates
and BBMV was determined by Western blotting as described
previously(15 – 17). Protein components of BBMV were separ-
ated by SDS-PAGE on 8 % (w/v) polyacrylamide mini gels,
containing 0·1 % (w/v) SDS, and electrotransferred to polyvi-
nylidene fluoride (PVDF) membrane (Immun-Blot; Bio-Rad
Laboratories Ltd, Hemel Hempstead, Herts, UK). The PVDF
membranes were blocked by incubating for 1 h at room
temperature in buffer PBS-TM (PBS containing 0·5 % (w/v)
non-fat dried milk and 0·05 % (v/v) Tween-20) then incubated
with SGLT1 antibody diluted 1:1000 in PBS-TM. The anti-
body to SGLT1 was raised in rabbits (custom synthesis) to
a synthetic peptide corresponding to amino acids 402–420
(STLFTMDIYTKIRKKASEK), a conserved intracellular loop
region of SGLT1(16,17) sharing 93·1 % identity to the swine
SGLT1 sequence. Immunoreactive bands were detected by
incubation for 1 h with affinity purified horseradish
peroxidase-linked anti-rabbit secondary antibody (Dako Ltd,
Cambridge, UK) diluted 1:2000 in PBS-TM solution, and
visualised using an Enhanced Chemiluminescence system
(GE Healthcare) according to the manufacturer’s instructions.
The intensity of the immunoreactive bands detected in
the BBMV was quantified using scanning densitometry
(Phoretix 1D quantifier; Non Linear Dynamics, Newcastle-
upon-Tyne, UK).
The PVDF membranes were stripped by 3 £ 10 min washes
in 137 mM-NaCl, 20 mM-glycine/HCl (pH 2·5) and then
probed with a monoclonal antibody to b-actin (1:20 000; clone
AC-15; Sigma Aldrich, Poole, Dorset, UK) as a loading control.
In order to determine the potential presence of GLUT2 in
the BBMV, the cellular homogenate and BBMV were
probed with antibodies to GLUT2 (either raised against the
C-terminus or residues 40–55 of the GLUT2 amino acid
sequence). The procedure was as described above for
SGLT1 Western blotting except that the reagent used to
block the PVDF membranes consisted of a buffer, PBS-TE
(PBS, 0·1 % (v/v) Triton X-100 and 0·1 mM-EDTA) with
5 % (w/v) non-fat dried milk, and PVDF membranes were
incubated with GLUT2 antibodies diluted 1:1000 in PBS-TE
þ1 % (w/v) non-fat dry milk.
RNA isolation, quantitative PCR
Total RNA isolated from intestinal tissue using the RNeasy
Mini Kit with on-column DNase 1 digestion (Qiagen, Crawley,
West Sussex, UK) was used for cDNA synthesis using
Superscript III reverse transcriptase (Invitrogen, Paisley, UK)
and random hexamer primers. cDNA was purified using the
QiaQuick PCR purification kit (Qiagen) and PCR assays
were performed using 25 ng cDNA per reaction. PCR primers
for the amplification of SGLT1 (SLC5A1; accession no.
M34044; sense 50-AAAGGAGAGGTCTGGGATGGTAA-30;
anti-sense 50-ATTTCCCTAGTGGCCTGAGATTG-30) along
with b-actin (ACTB; accession no. DQ452569; sense 50-CGA-
GGCCCAGAGCAAGAG-30; anti-sense 50-TCCATGTCGTC-
CCAGTTGGT-30) were designed using Primer Express
(Applied Bio-systems, Warrington, Cheshire, UK) and pur-
chased from Eurogentec (Seraign, Belgium). Each quantitative
PCR reaction contained 5ml of cDNA template (25 ng),
1 £ JumpStart Taq ReadyMix with SYBR green (Sigma
Aldrich), and 900 nM of each primer in a total volume of
25ml. Quantitative PCR cycling was performed as follows:
initial denaturation at 958C for 2 min followed by thirty-five
cycles of 958C for 15 s, 608C for 60 s. All reactions were
performed in triplicate using a Rotor-Gene 3000 (Qiagen
Ltd). Relative amounts of SGLT1 mRNA were normalised
to b-actin mRNA within each sample.
Immunohistochemistry
Immunohistochemistry was carried out based on previous
procedures(16). Sections of small intestine from proximal,
mid- and distal regions fixed for 4 h in 4 % (w/v) paraformal-
dehyde–PBS were placed in 20 % (w/v) sucrose (Fluka,
Gillingham, Dorset, UK) in PBS overnight. The tissue samples
were then gelatine embedded and frozen in liquid N2-cooled
isopentane before sectioning on a cryostat (Bright Instrument
Intestinal glucose transport in piglets 649
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Co. Ltd, Huntingdon, Cambs, UK). Sections, 10mm thickness,
were thaw-mounted onto polylysine-coated slides, and were
washed 5 £ 5 min in PBS followed by 1 h incubation in block-
ing solution (10 % (v/v) donkey serum in PBS) at 258C in a
humidifier chamber. Sections were incubated overnight at
48C with primary antibodies either against SGLT1, GLUT2
(C-terminus) or GLUT2 (residues 40–55), all diluted 1:100.
The antibody to SGLT1 was the same as that used in Western
blotting for the determination of SGLT1 protein abundance
(see above). One of the antibodies used for immunohistochem-
ical localisation of GLUT2 was raised in rabbits (custom
synthesis) to a synthetic peptide (AAVEMEFLGATETA)
corresponding to amino acids 511–524 of equine GLUT2
C-terminus region; there is 92·4 % identity in this region
between pig and horse GLUT2(16). The other antibody to
GLUT2 (ab1342; Millipore, UK) was raised against a peptide
(SHYRHVLGVPLDDRRA) corresponding to residues 40–55
of rat GLUT2 (sharing 87·5 % identity with the corresponding
pig sequence). Following incubation of sections with primary
antibodies, slides were washed with PBS as described earlier
and sections were stained using fluorochrome-labelled
reagents. Fluorescein isothiocyanate-conjugated IgG second-
ary antibodies (Stratech, Scientific Limited, New market,
Suffolk, UK) were used at a dilution of 1:500 for 1 h at
room temperature. Sections were washed thoroughly with
PBS as described earlier before mounting with Vectashield
hard mounting medium (Vector Laboratories Ltd, Peterbor-
ough, Cambs, UK). Immunofluorescent labelling of SGLT1,
and GLUT2 proteins on enterocyte plasma membrane
domains, along the crypt–villus axis, were visualised using
an epifluorescence microscope (Nikon, Kingston upon Thames,
Surrey, UK) and images were captured with a Hamamatsu
digital camera (C4742-96-12G04; Hamamatsu Photonics
K.K., Hamamatsu City, Japan). Omission of primary anti-
bodies was routinely used as the control. The amount of
specific fluorescent labelling for SGLT1 on the brush-border
membrane along the crypt–villus axis was determined as
described below. SGLT1 expression in the crypt was
negligible.
Quantitative immunohistochemistry for Naþ/glucose
co-transporter 1
Immunofluorescent images showing labelling for SGLT1
protein along crypt–villus axes were captured with a 10 £
objective using Imaging Products Laboratory software
(Nikon) and stored as 16-bit Tiff files. The quantitative
analyses were carried out using MetaMorph software (MDS
Analytical Technologies Ltd, Wokingham, Berks, UK).
To assure accurate quantification of SGLT1 protein, each
stage in the process was standardised. All villi were subject
to strict criteria, i.e. being intact, with well-orientated
SGLT1 labelling along both sides of the villus. MetaMorph
software ensures that binning (2 £ 2) and the white and
black points are kept constant throughout(18). Binning allows
several pixels to be grouped into a function unit reducing
the impact of read noise on the signal:noise ratio(18).
Parameters for image acquisition were set to make sure that
no pixel saturation of any image took place. At 10 £ magni-
fication, a 200 ms exposure time ensured that no saturated
pixels were formed, thus allowing quantification of the flor-
escence signal analysed to be in the linear range.
Each villus was divided into five equal areas lengthwise
from villus tip to the crypt–villus junction; horizontal lines
were placed longitudinally to separate each area (refer to
Fig. 4(a)). This eliminated the assessment of overlapping
areas. The first, third and fifth areas were designated as
upper villus, mid-villus and lower villus, respectively.
Analyses were carried out in these areas. Five regions of
interest (refer to Fig. 4(a)), each being of equal shape and
size (16 pixels in size), were positioned over the SGLT1
labelling on the brush-border membrane on either the right
or left side of the villus. The regions of interest were placed
at approximately equal distance covering the SGLT1 signal.
The integrated intensity for each region of interest was then
recorded automatically by the software for each area and the
average value was normalised to that in the crypt (the latter
having a negligible SGLT1 signal). Five villi were measured
per slide for three sections, five sections apart, for each
animal. A five-section gap between quantified sections was
used to ensure that the same villus was not accidentally
measured twice.
Morphometry
Morphometry was performed on 10mm cross-sections
prepared from frozen intestinal sections. Slides were exposed
to tap water for 15 s and incubated in Mayer’s Haemalum
(3·3 mM-Mayer’s Haemalum-haematoxylin, 1 mM-sodium
iodate, 0·42 mM-potassium alum) for 1 min before gently
washing with running tap water for 5 min. Slides were then
stained with eosin Y solution (1 % (w/v) eosin aqueous; HD
Supplies, Buckingham, Bucks, UK) for 10 s before washing
with 95 % (v/v) ethanol for 3 £ 1 min, and with absolute
ethanol 3 £ 1 min, followed by washing with xylene
3 £ 1 min and finally mounting with D.P.X. neutral mounting
medium (Sigma Aldrich).
Digital images were captured with an Eclipse E400 micro-
scope and DXM 1200 digital camera (Nikon) and analysed
using ImageJ software (Wayne Rasband, US National
Institutes of Health, Bethesda, MD, USA) calibrated using a
100mm gradient slide. Villus height was measured as the
average distance from villus base to villus tip from an average
of sixteen well-oriented villi per section, from at least eight
different cross-sections per tissue segment. Crypt depth was
calculated as the distance from crypt base to crypt–villus
junction for each specimen.
Statistical analysis
Analysis of changes in SGLT1 expression along the crypt–
villus axis (lower villus compared with mid- and upper villus)
was determined using a two-way ANOVA. A Bonferroni
post hoc test was used to determine significant differences in
SGLT1 expression in response to diets (7 to 60·3 % CHO
diets) in the crypt, lower, mid- and upper villus. All other
statistical analyses were performed using a Student’s t test.
All tests were carried out using GraphPad Prism 5 (GraphPad
Software, La Jolla, CA, USA). Results were considered
significant if P,0·05.
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Ethical approval
National/institutional guidelines for the care and use of animals
were followed and all experiments were approved by the
University of Liverpool ethics committee.
Results
Effect of increasing concentration of dietary carbohydrate
on Naþ/glucose co-transporter 1 expression
Piglets, aged 28 d, were weaned onto diets of varied CHO
content for 3 d. Animals were weighed daily and recorded
(see Table 2). On day 1 the animals lost between 200 and
400 g weight because they ate very little. However, by day
3, all regained the weight lost.
The expression of SGLT1 was measured at the level of
mRNA, protein and function. The amount of SGLT1 mRNA
in the mid-intestine of the piglets maintained on either the
7·0 or 35·9 % CHO diet was similar (Fig. 1(a)). However,
when piglets were fed either the 52·6 or 60·3 % CHO diet
the amount of SGLT1 mRNA was, respectively, 1·9-fold and
2-fold (P¼0·0015; P¼0·004) higher than that in piglets fed
the 7·0 or 35·9 % CHO diet (Fig. 1(a)).
The abundance of SGLT1 protein in BBMV from the
mid-small intestine was assessed by Western blotting
(Fig. 1(b)). In BBMV isolated from the intestine of piglets
fed the 52·6 and 60·3 % CHO diets, there were, respectively,
2·1-fold and 2·4-fold increases (P¼0·0412 and P¼0·0421) in
SGLT1 protein abundance as compared with piglets fed the
35·9 % CHO diet (Fig. 1(b)). This correlated with a 2·1-fold
(P¼0·0093) and 2·4-fold increase (P¼0·0002) in the initial
rate of Naþ-dependent D-glucose transport into the same
isolated BBMV (Fig. 1(c)). Mean uptake rates were 100·6
(SD 21·8), 209·3 (SD 20·3) and 237·6 (SD 13·9) pmol/s per
mg protein for the 35·9, 52·6 and 60·3 % CHO diets, respect-
ively. There was no significant difference in the levels of
SGLT1 mRNA, protein and glucose transport function in the
mid-intestine of the animals fed either the 52·6 or 60·3 %
CHO diet. Morphometric analysis indicated that neither
crypt depths nor villus heights differed in the intestines of
piglets fed either the 35·9 or 60·3 % CHO diet, ruling out a
trophic effect (Fig. 2).
SGLT1 expression in the proximal intestine was lower than
that in the mid-small intestine (Fig. 3). SGLT1 expression
in the proximal intestine of piglets fed the 60·3 % CHO
diet was significantly higher than that seen in the 35·9 %
CHO-fed group (2·2-fold increase; P¼0·0419; Fig. 3(a)).
This corresponded to a 1·7-fold change (P¼0·0015) in the
rate of D-glucose uptake in the proximal intestine of animals
fed the 60·3 % CHO diet compared with those fed the
35·9 % CHO diet (Fig. 3(b)). There was no up-regulation in
SGLT1 expression in the distal region of the intestine in
response to an increased CHO content of the diet (Fig. 3).
Profile of disaccharidase enzyme activities
The activities of the brush-border membrane disaccharidases,
sucrase and maltase, were determined in BBMV isolated
from the mid-small intestine of pigs fed either the 7·0, 35·9
or 60·3 % CHO diet. There was a 2·6-fold (P¼0·0392)
Table 2. Animal weights on days 0 and 3*
(Mean values and standard deviations)
Weight (kg)
Day 0 Day 3
Dietary CHO (%) Mean SD Mean SD
7·0 8·30 1·17 8·13 1·30
35·9 8·03 0·480 8·22 0·534
52·6 8·74 1·01 8·73 0·944
60·3 8·40 0·990 8·33 0·762
CHO, carbohydrate.
* The weight of each animal was recorded on each day of the study.
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Fig. 1. Expression of Naþ/glucose co-transporter 1 (SGLT1) is up-regulated when the carbohydrate (CHO) content of the diet exceeds intestinal glucose absorp-
tive capacity. Four groups of 28 d old piglets were weaned to isoenergetic diets containing 7·0, 35·9, 52·6 or 60·3 % CHO in the form of maize starch and sucrose.
The amount of feed and water provided each day was the same for all groups. In the mid-small intestine: (a) steady-state levels of SGLT1 mRNA as determined
by quantitative PCR and normalised to b-actin mRNA; (b) SGLT1 protein abundance in brush-border membrane vesicles (BBMV) assessed by Western blotting
(upper) and densitometric analysis (lower) of Western blots of SGLT1 protein expression normalised to that of b-actin; (c) SGLT1-mediated glucose uptake
measured by Naþ-dependent [U-14C]-D-glucose uptake into BBMV. Data were generated in triplicate, with five to nine animals in each group. Values are means,
with their standard errors represented by vertical bars. Mean value was significantly different from those of the groups fed the 7·0 and 35·9 % CHO diets:
* P,0·05, ** P,0·01, *** P,0·001 (Student’s t test).
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and 2·4-fold (P¼0·0303) increase in maltase activity in
BBMV isolated from the intestine of piglets fed the 35·9
and 60·3 % CHO diets, respectively, compared with animals
fed the 7·0 % CHO diet (Table 3). There were no statistically
significant differences in the activity of sucrase between the
groups fed the 7·0, 35·9 or 60·3 % diet (Table 3).
Quantitative immunofluorescence for Naþ/glucose
co-transporter 1
Having shown that there is an enhancement in intestinal
SGLT1 expression when CHO content of the diet is . 50 %, we
assessed where along the crypt–villus axis this increase occurs.
In all dietary conditions SGLT1 labelling was on the brush-
border membrane of the entire villus (Fig. 4(a)). The labelling
was specific; it was not observed when the primary antibody
was excluded (Fig. 4(b)). There was negligible expression
of SGLT1 in the crypt (Fig. 4(a)) as demonstrated in other
species(12,19). Quantitative immunohistochemistry showed
that the pattern of SGLT1 expression along the crypt–villus
axis of piglets fed the 7·0 % CHO diet was the same as
that of piglets fed the 35·9 % CHO diet, with SGLT1
expression 1·1-fold higher (P¼0001) in the mid-villus com-
pared with the upper villus (Fig. 4(c)). This pattern of
expression has been shown in other species(19,20). However,
when piglets were fed either the 52·6 or 60·3 % CHO diet,
the amount of SGLT1 protein in the mid- and upper villus
was, respectively, 1·9-fold, 1·6-fold and 1·4-fold higher
(P,0·0001) than that in piglets fed the 35·9 % CHO diet,
with higher expression in the mid- compared with the upper
villus (Fig. 4(c)).
Expression of GLUT2 in the small intestine
Using antibodies raised to either the C-terminus or residues
40–55 of GLUT2, we examined expression of GLUT2
in the small intestine of piglets. As shown in Fig. 5, both
antibodies reacted with a protein exclusively located on the
basolateral membrane of enterocytes of piglets maintained
on either the 7·0 % (Fig. 5(a) and (c)) or the 60·3 %
(Fig. 5(b) and (d)) CHO diet. No labelling was observed on
the brush-border membrane of enterocytes under either dietary
condition. Furthermore, using Western blotting and probing
cellular homogenate and BBMV with antibodies to GLUT2,
there was a negligible level of GLUT2 in the BBMV
compared with the cellular homogenate. In contrast, SGLT1
abundance was 15-fold enriched in the same population of
BBMV compared with the cellular homogenate.
These results correlated well with functional assays (Fig. 6).
Initial rates of Naþ-dependent D-glucose transport in BBMV
isolated from the intestinal tissues of piglets maintained
on the 35·9 and 60·3 % CHO diets were 100·6 (SD 21·8) and
237·6 (SD 13·9) pmol/s per mg protein for the 35·9 and
60·3 % CHO diets, respectively. When Naþ in the incubation
medium was replaced with Kþ, the rates were reduced to
4·56 (SD 1·09) and 4·94 (SD 0·62) pmol/s per mg protein
for the 35·9 and 60·3 % CHO diets, respectively. The rates
of 2-deoxy-D-glucose uptake into the same population of
BBMV were negligible and similar to glucose uptake in the
presence of a Kþ-gradient (see Fig. 6).
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Fig. 2. Mean crypt depth and villus height in intestinal segments from piglets
fed diets varying in carbohydrate (CHO) content. Frozen sections from the
mid-small intestine of piglets fed either 35·9 % (A) or 60·3 % ( ) CHO
were stained with haematoxylin and eosin. Villus height and crypt depth were
measured using ImageJ (Wayne Rasband, US National Institutes of Health,
Bethesda, MD, USA). Values are means, with their standard errors repre-
sented by vertical bars. No statistically significant differences were observed.
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Fig. 3. Changes in expression of Naþ/glucose co-transporter 1 (SGLT1) along the length of the intestine of piglets on low- and high-carbohydrate (CHO) diets.
Piglets were fed either a 35·9 % (A) or 60·3 % (p) CHO diet. (a) Steady-state levels of SGLT1 mRNA normalised to b-actin mRNA. (b) SGLT1-mediated glucose
uptake measured by Naþ-dependent-[U-14C]-D-glucose uptake into brush-border membrane vesicles. Data were generated in triplicate, with five to nine animals in
each group. Values are means, with their standard errors represented by vertical bars. Mean value was significantly different from that of the group fed the 35·9 %
CHO diet: * P,0·05, ** P,0·01, *** P,0·001 (Student’s t test).
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Discussion
SGLT1 is the rate-limiting step for absorption of dietary
glucose from the lumen of the intestine into the body. Regu-
lation of this protein is essential for the provision of glucose
and, thus, has important nutritional implications.
We have previously shown that sweet taste receptor hetero-
dimers (T1R2/T1R3) are expressed in the intestinal enteroen-
docrine cells(12,21), and that these cells are in direct contact
with the lumer of the intestine through their apical exten-
sions(9). We further demonstrated that T1R2/T1R3 with the
G-protein, gustducin, are part of a sugar-sensing regulatory
machinery that regulates SGLT1 expression in response to
high dietary CHO. In wild-type mice kept on a high-CHO
(70 %) diet for 2 weeks, the expression of SGLT1 was 2-fold
higher than in mice maintained on a low-CHO (1·9 %)
diet(12,22). However, a-gustducin- and T1R3-knockout mice
showed no change in SGLT1 expression; on either diet, the
amount of SGLT1 mRNA, protein and function in both
types of knockout mice was identical to that of wild-type
animals on the low-CHO diet.
We proposed that there is a constitutive pathway, indepen-
dent of luminal sugar sensing by T1R3 and a-subunit of
gustducin, that maintains the basal expression of SGLT1 and
an inducible pathway dependent on T1R3 and a-gustducin.
The data suggested that luminal glucose when above a
threshold activates, in enteroendocrine sensor cells, a signal-
ling pathway involving T1R2 þ T1R3, a-gustducin and
other taste signalling elements(12). This results in the secretion
of gut hormones implicated in SGLT1 up-regulation(23,24) in
the neighbouring absorptive enterocytes.
Recent data in our laboratory have shown that when wild-type
mice were fed for 3 h on either a high-CHO (70 %) or maintained
on a low-CHO (1·9 %) diet, the magnitude of up-regulation
in SGLT1 expression was identical to those maintained for
2 weeks(12), indicating that enhanced expression of SGLT1 in
response to the intake of a high-CHO diet is a rapid process.
In the present paper we aimed to determine the approximate
threshold concentration of CHO required for the activation
of SGLT1 up-regulation. Four groups of 28 d old suckling
piglets were weaned onto and maintained on isoenergetic
diets with differing amounts of CHO for 3 d. Afterwards, the
piglets were killed, and intestinal tissues removed for our
analyses. We showed that SGLT1 expression remained
constant in the intestine of piglets when fed the 7·0 or
35·9 % CHO-containing diets. However, when they were fed
either the 52·6 or 60·3 % CHO diet there was a coordinated
increase in intestinal SGLT1 mRNA, protein abundance and
Naþ-dependent glucose transport. This implies that the
cellular level of control is at the level of mRNA abundance.
It appears, therefore, that the basal level of SGLT1 is suffi-
cient to absorb glucose up to certain concentrations. However,
the intestinal capacity to absorb glucose becomes limiting
when concentration of the CHO content of the diet reaches
about 50–60 %. This concentration is detected, leading to
the activation of pathway(s) regulating SGLT1 expression(12).
It has been proposed that in the intestine of rodents, in
response to either an intake of high dietary CHO, or infusion
with high concentrations of glucose or fructose, GLUT2 is
translocated to the luminal domain of enterocytes to transport
both glucose and fructose(3,4,25). The same authors have also
suggested that the antibody targeted to residues on the extra-
cellular loop between transmembrane regions 1 and 2, but not
the antibody targeted to the C-terminus region of GLUT2,
reacts with a protein on the brush-border membrane of rat
enterocytes(3). The data presented, however, are open to
interpretations that differ from the conclusions made.
In our studies using both antibodies raised to either the
C-terminus or extracellular loop we showed that GLUT2 is
exclusively expressed on the basolateral membrane of piglets’
enterocytes irrespective of dietary CHO content (Fig. 4).
This observation was supported by our functional studies.
There was negligible uptake of 2-deoxy-D-glucopyranoside,
a specific substrate of Naþ-independent glucose transporters,
into BBMV isolated from the intestines of piglets maintained
either on the 35·9 or 60·3 % CHO diet. The same BBMV,
Table 3. Disaccharidase activity†
(Mean values with their standard errors for four to six animals per
group)
Specific activity (mmol/min per mg protein)
Maltase Sucrase
Dietary CHO (%) Mean SEM Mean SEM
7·0 0·306 0·050 0·120 0·030
35·9 0·788* 0·075 0·110 0·016
60·3 0·758* 0·061 0·120 0·017
CHO, carbohydrate.
* Mean value was significantly different from that of the piglets fed the 7·0 % CHO
diet (P,0·05).
† Specific activities of sucrase and maltase were measured in brush-border mem-
brane vesicles isolated from the mid-small intestine of piglets fed either a 7·0,
35·9 or 60·3 % CHO-containing diet.
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Fig. 4. Immunofluorescent localisation of Naþ/glucose co-transporter 1
(SGLT1) along the crypt–villus axis of the small intestine. (a) Representative
immunofluorescent image showing labelling for SGLT1 protein on the brush-
border membrane of the entire villus of piglets fed a 60·3 % carbohydrate
(CHO) diet. UV, upper villus; MV, mid-villus; LV, lower villus. There is
negligible labelling in the crypt. No labelling was observed with omission of the
primary antibody (b). Regions of interest are shown as circles. Image (a) is
100 £ magnified, scale bar ¼ 100mm; image (b) is 200 £ magnified, scale
bar ¼ 10mm. (c) Quantitative immunofluorescent labelling of SGLT1 abun-
dance along the crypt–villus axis. Sections of 10mm of small intestine from
piglets fed 7·0 % (A), 35·9 % ( ), 52·6 % ( ) or 60·3 % ( ) CHO were immu-
nostained for SGLT1. The abundance of SGLT1 protein in crypt (C), LV, MV
or UV was quantified using Metamorph software (MDS Analytical Techno-
logies Ltd, Wokingham, Berks, UK) and normalised to immunofluorescent
labelling in the crypt. Values are means, with standard deviations represented
by vertical bars. Statistical significance was determined using a two-way
ANOVA with a Bonferroni post hoc test. * Mean value was significantly
different from those of the groups fed the 7·0 and 35·9 % CHO diets (P,0·001).
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however, could transport glucose in an Naþ-dependent
manner. Furthermore, using Western blotting, we showed a
negligible level of GLUT2 in BBMV, although the same
population of BBMV expresses high levels of SGLT1. In sup-
port of latter findings, Cui et al.(26) have shown, by Western
blotting, that GLUT2 is not expressed on the brush-border
membrane of rat enterocytes luminally perfused in vivo with
either 100 mM-fructose or 100 mM-glucose for 4 h(26). Basolat-
eral location for GLUT2 in the intestine of horses maintained
on a high-CHO diet (grain) has also been observed(16),
supporting the function of GLUT2 in the intestine to be the
basolateral membrane monosaccharide transporter. Collec-
tively our data support the conclusion that SGLT1 is the
major route for the absorption of dietary glucose across the
luminal membrane of pig enterocytes.
We showed that the rate of glucose absorption in the small
intestine of the piglet is mid . proximal . distal regions.
Furthermore, we determined that up-regulation in SGLT1
expression occurs in the proximal and mid, but not in the
distal region of the small intestine. The reason for lack of
response in the distal region is not known and is worth
investigating. Using quantitative immunohistochemistry, we
determined that the enhancement in SGLT1 expression
(a)
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BBM
(b)
BLM
BBM
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BLM
BBM
(d)
BLM
BBM
(e)
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GLUT2
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Fig. 5. GLUT2 is expressed on the basolateral membrane of enterocytes. Immunofluorescence was carried out on 10mm sections of mid-small intestine.
Representative images showing expression of GLUT2 in the intestine of piglets, fed 7·0 % (a and c) or 60·3 % (b and d) carbohydrate (CHO) diets, either using an
antibody raised against the C-terminus region of the GLUT2 amino acid sequence (a and b) or an antibody raised against a peptide corresponding to residues
40–55 of GLUT2 (c and d). (e) Primary antibody omitted control. Images (a)–(d) are 1000 £ and image (e) is 200 £ magnified, scale bar ¼ 10mm. Brush-border
membrane (BBM) and basolateral membrane (BLM) are marked. (f) Cellular homogenate (H) and brush-border membrane vesicles (BBMV) from the mid-small
intestine of piglets fed a 60·3 % CHO diet, immune-blotted for Naþ/glucose co-transporter 1 (SGLT1) and GLUT2 proteins.
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Fig. 6. D-Glucose and 2-deoxy-D-glucose uptake into brush-border mem-
brane vesicles (BBMV). Initial rates of [U-14C]-D-glucose uptake in the
presence of a Naþ- (A) or Kþ-gradient ( ), or 2-deoxy-[U-14C]-D-glucose (p)
uptake into BBMV, isolated from the mid-small intestine of piglets fed either
a 35·9 or 60·3 % carbohydrate (CHO) diet, were measured. Data were gener-
ated in triplicate, with five to nine animals in each group. Values are means,
with their standard errors represented by vertical bars. *** Mean value was
significantly different from that of the group fed the 35·9 % CHO diet
(P,0·001; Student’s t test).
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along the crypt–villus axis initiated by a high-CHO diet
is manifested in mid . upper . lower villus regions. The
increase in SGLT1 expression is not due to trophic effects.
Morphometric analysis indicated that there were no changes
in villus height and crypt depth between animals maintained
on low- or high-CHO diets. Interestingly, there was a
2·4-fold increase in specific activity of maltase, but not
sucrase, in BBMV isolated from the intestine of piglets main-
tained on the 60·3 % CHO diet compared with those fed the
7·0 % CHO diet.
CHO is a major constituent of the swine diet and is an
important source of energy, in particular for growing piglets.
It is also an expensive component of the diet. A better under-
standing of the precise mechanism by which dietary glucose
is absorbed in the intestine of the weaning piglets, and
the recognition that the process is dietary induced and not
genetically pre-programmed, will facilitate the development
of rational strategies to enhance the capacity of the intestine
to absorb dietary sugars. Furthermore, this knowledge
will assist a more scientifically based approach to designing
feed formulation and supplementations with the ultimate aim
of enhancing the health of the young piglets and reducing
the incidence of post-weaning intestinal disorders.
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